| 查看: 396 | 回复: 20 | ||
| 当前主题已经存档。 | ||
| 【悬赏金币】回答本帖问题，作者chendiqing将赠送您 30 个金币 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
chendiqing铁杆木虫 (知名作家)
|
[求助]
查文献的题目，一个5金币，难找的一个10~20金币啊【已解决，谢谢大家】
|
|
|
各位兄弟姐妹们，帮忙查一下以下文献的题目啊，就只它文献的题目就可以了，找到一个5金币，难找的一个10~20金币不等，拜托了啊~~~~ 1，Biginelli , P. Gazz. Chim. Ital . 1893 , 23 , 360. 2，Kappe , C. O. Tetrahedron 1993 , 49 , 6937. 3，Grover , G. J . ; Dzwonczyk , S. ; McMullen , D. M. ; Grover ,C. S. ; Sleph , P. G. ; Moreland , S. J . J . Cardiovasc. Pharmacol . 1995 , 26 , 289. 4，Atwal , K. S. ; Swanson , B. N. ; Unger , S. E. ; Floyd , D. M. ; Moreland , S. ; Hedberg , A. ; O′eilly , B. C. J . Med. Chem. 1991 , 34 , 806. 5，Rovnyak , G. C. ; Atwal , K. S. ; Hedberg , A. ; Kim2 ball , S. D. ; Moreland , S. ; Gougoutas , J . Z. ; O’eil2ly , B. C. ; Schwartz , J . ; Malley , M. F. J . Med.Chem. 1992 , 35 , 3254. 6，Nagarathnam , D. ; Miao , S. W. ; Lagu , B. ; Chiu , G. ; Fang , J . ; MDhar , T. G. ; Zhang , J . ; Tyagarajan , S. ; Marzabadi , M. R. ; Zhang , F. Q. ; Wong , W. C. ; Sun , W. Y. ; Tian , D. ; Wetzel , J . M. ; Forray , C. ; Chang , R. S. L. ;Broten , T. P. ; Ransom , R. W. ;Schorn , T. W. ; Chen , T. B. ; O′Malley , S. ;Kling , P. ; Schneck , K. ; Benedesky , R. ; Harrell , C. M. ; Vyas , K. P. ;Gluchowski , C. J . Med. Chem. 1999 , 42 , 4764. 7，Barrow , J . C. ; Nantermet , P. G. ; Selnick , H. G. ; Glass , K. L. ; Rittle , K. E. ; Gilbert , K. F. ; Steele , T. G. ; Homnick , C. F. ; Freidinger , R. M. ; Ransom , R. W. ; Kling , P. ; Reiss , D. ; Broten , T. P. ; Schorn , T. W. ; Chang , R. S. L. ; O′Malley , S. S. ; Olah , T. V. ; Ellis , J . D. ; Barrish , A. ; Kassahun , K. ; Leppert , P. ; Nagarathnam , D. ; Forray , C. J . Med. Chem. 2000 , 43 , 2703. 8，Ma , Y. ; Qian , C. ; Wang , L. ; Yang , M. J . Org. Chem. 2000 , 65 , 3864. 9，Ranu , B. C. ; Hajra , A. ; Jana , U. J . Org. Chem. 2000 , 65 , 6270. 10，Wipf , P. ; Cunningham , A. Tetrahedron Lett . 1995 , 36 ,7819. 11，Studer , A. ; Jeger , P. ; Wipf , P. ; Curran , D. P. J . Org.Chem. 1997 , 62 , 2917. [ Last edited by zzgyb on 2008-7-17 at 10:57 ] |
回复此楼» 猜你喜欢
各位老师好，我的一志愿为北京科技大学085601材料专硕
已经有12人回复
-
359求调剂
已经有7人回复
-
070300化学专业279调剂
已经有10人回复
-
环境工程297分求调剂一志愿杭高院
已经有9人回复
-
一志愿武理材料工程302调剂环化或化工
已经有9人回复
-
309分085801求调剂
已经有5人回复
-
一志愿 南京航空航天大学 ，080500材料科学与工程学硕
已经有5人回复
-
材料调剂
已经有4人回复
-
材料调剂
已经有3人回复
-
311（085601）求调剂
已经有12人回复
7楼2008-06-16 22:27:50
2楼2008-06-16 22:09:27
3楼2008-06-16 22:13:01
★ ★ ★ ★ ★
chendiqing(金币+5,VIP+0):哇哦，谢谢哥们你啊~~~~
chendiqing(金币+5,VIP+0):哇哦，谢谢哥们你啊~~~~
|
3.Titre du document / Document title Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,946 Auteur(s) / Author(s) GROVER G. J. ; DZWONCZYK S. ; MCMULLEN D. M. ; NORMANDIN D. E. ; PARHAM C. S. ; SLEPH P. G. ; MORELAND S. ; Affiliation(s) du ou des auteurs / Author(s) Affiliation(s) Bristol-Myers Squibb pharmaceutical res. inst., dep. pharmacology, Princeton NJ 08543, ETATS-UNIS Résumé / Abstract SQ 32,926 and SQ 32,547, two dihydropyrimidine calcium channel blockers, were characterized as potent inhibitors of depolarization-induced contractions of isolated smooth muscle preparations. In rat aorta, the IC50 values were 5.5 nM for SQ 32,547 and 8.1 nM for SQ 32,926, values which compare favorably with that of 2.9 nM for nifedipine. The dihydropyrimidines were also tested in a model of stable angina : pacing-induced ischemia in dogs. Both SQ 32,547 and SQ 32,926 reduced the ST-segment elevation observed in vehicle-treated animals. No significant changes in hemodynamic status were detected, suggesting that a reduction in cardiac work secondary to afterload reduction was probably not a major contributor to the protective effects. Neither was increased coronary blood flow important for the antiischemic outcome because no significant effects of the dihydropyrimidines were observed on ischemic regional blood flow. SQ 32,547 was also studied in globally ischemic, isolated rat hearts. In this model, SQ 32,547 was protective because it significantly reduced contracture formation and lactate dehydrogenase (LDH) release. Washing out the effect of SQ 32,547 in isolated hearts and smooth muscles was difficult, presumably due to its lipophilicity. In the smooth muscle preparations, the effects of both nifedipine and SQ 32,926 were much more easily washed out. As with other calcium channel blockers, increasing the antiischemic effects of SQ 32,547 was associated with a higher cost in terms of cardiac function. In summary, the two novel dihydropyrimidines, SQ 32,547 and SQ 32,926, showed antiischemic properties in animal models. Revue / Journal Title Journal of cardiovascular pharmacology ISSN 0160-2446 CODEN JCPCDT Source / Source 1995, vol. 26, no2, pp. 289-294 (24 ref.) Langue / Language Anglais Editeur / Publisher Lippincott, Hagerstown, MD, ETATS-UNIS (1979) (Revue) Mots-clés anglais / English Keywords Calcium antagonist ; Antiïschemic ; Angina pectoris ; Chemotherapy ; Treatment ; Smooth muscle ; Heart ; Rat ; Animal ; In vivo ; In vitro ; Rodentia ; Mammalia ; Vertebrata ; Cardiovascular disease ; Coronary heart disease ; Mots-clés français / French Keywords Antagoniste calcium ; Antiischémique ; Angine poitrine ; Chimiothérapie ; Traitement ; Muscle lisse ; Coeur ; Rat ; Animal ; In vivo ; In vitro ; SQ 32 547 ; SQ 32 946 ; Dihydropyrimidine dérivé ; Cardioprotecteur ; Rodentia ; Mammalia ; Vertebrata ; Appareil circulatoire pathologie ; Cardiopathie coronaire ; Mots-clés espagnols / Spanish Keywords Antagonista calcio ; Antiisquémico ; Angina pectoris ; Quimioterapia ; Tratamiento ; Músculo liso ; Corazón ; Rata ; Animal ; In vivo ; In vitro ; Rodentia ; Mammalia ; Vertebrata ; Aparato circulatorio patología ; Cardiopatía coronaria ; Localisation / Location INIST-CNRS, Cote INIST : 18065, 35400005361515.0140 |
4楼2008-06-16 22:15:46
